Ashuvinee Elangovan, Ph.D. successfully convinced her committee that her project entitled “Loss of E-Cadherin Activates a Targetable IF1R Pathway in Invasive Lobular Breast Cancer” is worthy of a Philosophiae Doctor! Cheers to Ashu!!
![](https://leeoesterreich.org/wp-content/uploads/2022/03/IMG_1248-1-768x1024.png)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/AshuDefense_01-1024x987.jpg)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/AshuDefense_05-1024x983.jpg)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/AshuDefense_06-1024x768.jpg)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/AshuDefense_08-1024x768.jpg)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/AshuDefense_09-1024x768.jpg)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/AshuDefense_07-1024x768.jpg)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/AshuDefense_11-768x1024.jpg)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/IMG_1254-768x1024.png)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/IMG_1269-768x1024.png)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/AshuDefense_04-768x1024.jpg)
![](https://leeoesterreich.org/wp-content/uploads/2022/03/IMG_1197-2-1024x768.png)
Ashuvinee Elangovan, Ph.D. successfully convinced her committee that her project entitled “Loss of E-Cadherin Activates a Targetable IF1R Pathway in Invasive Lobular Breast Cancer” is worthy of a Philosophiae Doctor! Cheers to Ashu!!